Hemp, Inc (HEMP)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5019.78 | -15.14 Million | -12.11 Million | -14.6 Million | -10.25 Million | -5.56 Million |
| Net Income | -5482.15 | -25.35 Million | -12.86 Million | -26.61 Million | -38.73 Million | -39.34 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1047.84 | 10.55 Thousand | 1469.90 | 4843.26 | 7656.69 | 6842.80 |
| Change in working capital | -3.16 | -334.96 Thousand | -715.64 Thousand | -6.27 Million | -3.74 Million | 1.03 Million |
| Other non-cash items | -582.31 | 10.88 Million | 78.26 Thousand | 23.54 Million | 33.32 Million | 32.84 Million |
| Investing Cash Flow | 597.98 | 305.46 Thousand | -199.97 Thousand | -9.8 Million | -3.82 Million | -1.1 Million |
| Investments in PPE | -1.00 | - | -199.97 Thousand | -9.8 Million | -3.82 Million | -1.48 Million |
| Acquisitions | 597.97 Thousand | 305.46 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | 383.46 Thousand |
| Other Investing Activities | 597.98 | - | - | - | - | 383.46 |
| Financing Cash Flow | 4118.22 | 14.24 Million | 9.15 Million | 24.26 Million | 14.09 Million | 6.71 Million |
| Debt repayment | -1750.00 | -2.69 Million | -3.32 Million | -8.82 Million | -3.25 Million | -6.71 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 2368.22 | 11.54 Million | 5.83 Million | 15.43 Million | 10.83 Million | -33.80 |
| Accounts receivables | -10.89 | -81.47 Thousand | -24.01 Thousand | -1.5 Million | -392.57 Thousand | 7526.00 |
| Accounts payables | -582.3 Thousand | -66.77 Thousand | 690.99 Thousand | 119.01 Thousand | -24.66 Thousand | 40.1 Thousand |
| Inventory | 7.73 | -186.71 Thousand | 724.65 Thousand | -3.87 Million | -674.15 Thousand | -147.72 Thousand |
| Other working capital | - | - | -2.1 Million | -1.01 Million | -2.65 Million | 1.13 Million |
| Cash at beginning of period | 247.5 Thousand | 103.88 Thousand | 245.23 Thousand | 396.2 Thousand | 386.42 Thousand | 306.44 Thousand |
| Cash at end of period | 96.16 | 247.5 Thousand | 103.88 Thousand | 245.23 Thousand | 396.2 Thousand | 386.42 Thousand |
| Capital Expenditure | -1.00 | - | -199.97 Thousand | -9.8 Million | -3.82 Million | -1.48 Million |
| Effect of forex changes on cash | 152.23 Thousand | 738.71 Thousand | 3.01 Million | 151.2 Thousand | - | - |
| Net cash flow / Change in cash | -247.4 Thousand | 143.62 Thousand | -141.35 Thousand | -150.96 Thousand | 9782.00 | 79.97 Thousand |
| Free Cash Flow | -5020.78 | -15.14 Million | -12.31 Million | -24.41 Million | -14.08 Million | -7.05 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | -952.51 Thousand | -5.48 Million | -1.58 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | 1047.84 | 1019.51 |
| Change in working capital | - | - | - | 173.02 Thousand | -585.47 Thousand | -297.88 Thousand |
| Other non-cash items | - | - | - | -3.08 Million | 1.63 Million | 4.23 Million |
| Investing Cash Flow | - | - | - | 150 Thousand | 597.97 Thousand | 2021.00 |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | 150 Thousand | 597.97 Thousand | 2021.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -147.98 | 597.98 | 447.98 |
| Financing Cash Flow | - | - | - | 2.19 Million | 4.11 Million | -1.45 Million |
| Debt repayment | - | - | - | -205 Thousand | -1.75 Million | -215 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | 1.98 Million | 2.36 Million | -1.24 Million |
| Accounts receivables | - | - | - | 39.11 Thousand | -10.88 Thousand | -50 Thousand |
| Accounts payables | - | - | - | 123.79 Thousand | -582.3 Thousand | -269.24 Thousand |
| Inventory | - | - | - | 10.11 Thousand | 7725.00 | 21.35 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | 96.16 Thousand | 69.69 Thousand | 247.5 Thousand | 29.63 Thousand |
| Cash at end of period | - | - | 96.16 Thousand | 96.16 Thousand | 96.16 Thousand | 69.69 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | 1.37 Million | 152.23 Thousand | -553.7 Thousand |
| Net cash flow / Change in cash | - | - | - | 26.46 Thousand | -151.34 Thousand | 40.06 Thousand |
| Free Cash Flow | - | - | - | -3.69 Million | -5.01 Million | 2.04 Million |
603867
2185
DKS
0P49
SMSPHARMA
STLJF